project id: TCGA-GBM; case submitter id: TCGA-06-6698; analyte type: Total RNA; analyte type id: T; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; analyte volume: 20.0; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 53; days to birth: -19591; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1958; age at diagnosis: 19591; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 145.0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.0; longest dimension: 1.0; preservation method: Unknown; shortest dimension: 0.7; sample id: a09cf491-962b-4119-abc2-1c5049ee017f; sample submitter id: TCGA-06-6698-01A; portion id: 449871e3-4aec-40ae-8c8e-d7ab2871dd20; portion submitter id: TCGA-06-6698-01A-11; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor nuclei: 85.0;